Logo-jnp
J Nephropathol. 2017;6(2): 58-62. doi: 10.15171/jnp.2017.10
PMID: 28491854        PMCID: PMC5418071

Case Report

MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature

Mário Góis * , Ana Messias, Dulce Carvalho, Fernanda Carvalho, João Sousa, Helena Sousa, Fernando Nolasco

Cited by CrossRef: 5


1- Carvajal Alegria G, Groh M, Guellec D, Toussirot E, Rigaud J, Soubrier M, Ottaviani S, Direz G, Saraux A, Cornec D. Anti-neutrophil cytoplasmic antibody-associated chronic inflammatory arthritis without vasculitis. Data from a French nationwide survey. Autoimmunity Reviews. 2018;17(12):1268 [Crossref]
2- Moiseev S, Cohen Tervaert J, Arimura Y, Bogdanos D, Csernok E, Damoiseaux J, Ferrante M, Flores-Suárez L, Fritzler M, Invernizzi P, Jayne D, Jennette J, Little M, McAdoo S, Novikov P, Pusey C, Radice A, Salama A, Savige J, Segelmark M, Shoenfeld Y, Sinico R, Sousa M, Specks U, Terrier B, Tzioufas A, Vermeire S, Zhao M, Bossuyt X. 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmunity Reviews. 2020;19(9):102618 [Crossref]
3- Chessa E, Piga M, Floris A, Congia M, Cangemi I, Mathieu A, Cauli A. Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review. BioDrugs. 2021;35(2):175 [Crossref]
4- Brevet P, Curie A, Princivil C, Zarnitsky C, Alcaix D. Vascularites à ANCA précédées d’une atteinte articulaire isolée. À propos de deux cas et revue de la littérature. La Revue de Médecine Interne. 2021;42(9):650 [Crossref]
5- Martín-Nares E, Zuñiga-Tamayo D, Hinojosa-Azaola A. Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity. Clin Rheumatol. 2019;38(1):97 [Crossref]
6- Jayashree S, Nirekshana K, Guha G, Bhakta-Guha D. Cancer chemotherapeutics in rheumatoid arthritis: A convoluted connection. Biomedicine & Pharmacotherapy. 2018;102:894 [Crossref]
7- Disease-modifying antirheumatic drugs. Reactions Weekly. 2017;1640(1):139 [Crossref]